Danilo Giuseppe Faraci
Overview
Explore the profile of Danilo Giuseppe Faraci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallazzi M, Ucciero M, Faraci D, Mahmoud A, Al Essa W, Gaidano G, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35886899
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represent an unmet clinical need whose prognosis is still dismal. Alterations of immune response play a prominent role in AML/MDS pathogenesis, revealing...
2.
Butera S, Cerrano M, Brunello L, Dellacasa C, Faraci D, Vassallo S, et al.
Ann Hematol
. 2021 May;
100(7):1837-1847.
PMID: 33948721
Despite the widespread use of rabbit anti-thymocyte globulin (ATG) to prevent acute and chronic graft-versus-host disease (aGVHD, cGVHD) after allogeneic hematopoietic cell transplantation (allo-HCT), convincing evidence about an optimal dose...
3.
Giaccone L, Faraci D, Butera S, Lia G, Di Vito C, Gabrielli G, et al.
Expert Rev Hematol
. 2020 Dec;
14(1):79-96.
PMID: 33297779
Introduction: Despite significant advances in treatment and prevention, graft-versus-host disease (GVHD) still represents the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Thus, considerable research efforts...
4.
Cerrano M, Ruella M, Perales M, Vitale C, Faraci D, Giaccone L, et al.
Front Immunol
. 2020 Jun;
11:888.
PMID: 32477359
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two...